Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OLMESARTAN MEDOXOMIL Cause Angle closure glaucoma? 5 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Angle closure glaucoma have been filed in association with OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL). This represents 0.0% of all adverse event reports for OLMESARTAN MEDOXOMIL.

5
Reports of Angle closure glaucoma with OLMESARTAN MEDOXOMIL
0.0%
of all OLMESARTAN MEDOXOMIL reports
0
Deaths
5
Hospitalizations

How Dangerous Is Angle closure glaucoma From OLMESARTAN MEDOXOMIL?

Of the 5 reports, 5 (100.0%) required hospitalization.

Is Angle closure glaucoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OLMESARTAN MEDOXOMIL. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does OLMESARTAN MEDOXOMIL Cause?

Sprue-like enteropathy (3,482) Gastrooesophageal reflux disease (1,819) Acute kidney injury (1,587) Weight decreased (1,569) Haemorrhoids (1,316) Diarrhoea (1,300) Hiatus hernia (938) Dizziness (885) Large intestine polyp (839) Constipation (796)

What Other Drugs Cause Angle closure glaucoma?

TOPIRAMATE (345) ACETAZOLAMIDE (51) PHENTERMINE\TOPIRAMATE (37) DULOXETINE (36) ESCITALOPRAM OXALATE (36) ALBUTEROL (35) QUETIAPINE (34) HYDROCHLOROTHIAZIDE (33) ADALIMUMAB (32) DEXAMETHASONE (30)

Which OLMESARTAN MEDOXOMIL Alternatives Have Lower Angle closure glaucoma Risk?

OLMESARTAN MEDOXOMIL vs OLMETEC OLMESARTAN MEDOXOMIL vs OLODATEROL OLMESARTAN MEDOXOMIL vs OLODATEROL\TIOTROPIUM OLMESARTAN MEDOXOMIL vs OLOPATADINE OLMESARTAN MEDOXOMIL vs OLUTASIDENIB

Related Pages

OLMESARTAN MEDOXOMIL Full Profile All Angle closure glaucoma Reports All Drugs Causing Angle closure glaucoma OLMESARTAN MEDOXOMIL Demographics